Mar 13, 2017 7:00 am EDT Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2
Mar 02, 2017 8:00 am EST Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting
Feb 17, 2017 7:00 am EST Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium
Jan 05, 2017 8:00 am EST Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco
Dec 06, 2016 8:20 am EST Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results